Literature DB >> 20966398

Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells.

Peter Gin1, Anne P Beigneux, Constance Voss, Brandon S J Davies, Jennifer A Beckstead, Robert O Ryan, André Bensadoun, Loren G Fong, Stephen G Young.   

Abstract

OBJECTIVE: To define the ability of GPIHBP1 to bind other lipase family members and other apolipoproteins (apos) and lipoproteins. METHODS AND
RESULTS: GPIHBP1, a GPI-anchored lymphocyte antigen (Ly)6 protein of capillary endothelial cells, binds lipoprotein lipase (LPL) avidly, but its ability to bind related lipase family members has never been evaluated. As judged by cell-based and cell-free binding assays, LPL binds to GPIHBP1, but other members of the lipase family do not. We also examined the binding of apoAV-phospholipid disks to GPIHBP1. ApoAV binds avidly to GPIHBP1-transfected cells; this binding requires GPIHBP1's amino-terminal acidic domain and is independent of its cysteine-rich Ly6 domain (the latter domain is essential for LPL binding). GPIHBP1-transfected cells did not bind high-density lipoprotein. Chylomicrons bind avidly to GPIHBP1-transfected Chinese hamster ovary cells, but this binding is dependent on GPIHBP1's ability to bind LPL within the cell culture medium.
CONCLUSIONS: GPIHBP1 binds LPL but does not bind other lipase family members. GPIHBP1 binds apoAV but does not bind apoAI or high-density lipoprotein. The ability of GPIHBP1-transfected Chinese hamster ovary cells to bind chylomicrons is mediated by LPL; chylomicron binding does not occur unless GPIHBP1 first captures LPL from the cell culture medium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20966398      PMCID: PMC3004026          DOI: 10.1161/ATVBAHA.110.214718

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  27 in total

1.  Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1.

Authors:  Ryoichi X Ioka; Man-Jong Kang; Shin Kamiyama; Dong-Ho Kim; Kenta Magoori; Akihisa Kamataki; Yuichiro Ito; Yumiko A Takei; Masako Sasaki; Takashi Suzuki; Hironobu Sasano; Sadao Takahashi; Juro Sakai; Takahiro Fujino; Tokuo T Yamamoto
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

2.  Immunochemical heterogeneity of human plasma high density lipoproteins. Identification with apolipoprotein A-I- and A-II-specific monoclonal antibodies.

Authors:  L K Curtiss; T S Edgington
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

3.  Interaction of the N-terminal domain of apolipoprotein E4 with heparin.

Authors:  J Dong; C A Peters-Libeu; K H Weisgraber; B W Segelke; B Rupp; I Capila; M J Hernáiz; L A LeBrun; R J Linhardt
Journal:  Biochemistry       Date:  2001-03-06       Impact factor: 3.162

4.  Mapping of the epitope on lipoprotein lipase recognized by a monoclonal antibody (5D2) which inhibits lipase activity.

Authors:  M S Liu; Y Ma; M R Hayden; J D Brunzell
Journal:  Biochim Biophys Acta       Date:  1992-09-22

5.  Chimeras of hepatic lipase and lipoprotein lipase. Domain localization of enzyme-specific properties.

Authors:  R C Davis; H Wong; J Nikazy; K Wang; Q Han; M C Schotz
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

6.  Human apolipoprotein B-100 heparin-binding sites.

Authors:  K H Weisgraber; S C Rall
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

7.  Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.

Authors:  K H Weisgraber; S C Rall; R W Mahley; R W Milne; Y L Marcel; J T Sparrow
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

8.  Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain.

Authors:  A Hata; D N Ridinger; S Sutherland; M Emi; Z Shuhua; R L Myers; K Ren; T Cheng; I Inoue; D E Wilson
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

9.  Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway.

Authors:  Ilia V Fuki; Nadine Blanchard; Weijun Jin; Dawn H L Marchadier; John S Millar; Jane M Glick; Daniel J Rader
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

10.  Characterization of monoclonal antibodies against human apolipoprotein E.

Authors:  R W Milne; P Douste-Blazy; Y L Marcel; L Retegui
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

View more
  30 in total

1.  Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.

Authors:  Constance V Voss; Brandon S J Davies; Shelly Tat; Peter Gin; Loren G Fong; Christopher Pelletier; Charlene D Mottler; André Bensadoun; Anne P Beigneux; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase.

Authors:  André Bensadoun; Charlene D Mottler; Chris Pelletier; Daniel Wu; Jane J Seo; Calvin S Leung; Oludotun Adeyo; Chris N Goulbourne; Peter Gin; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  Biochim Biophys Acta       Date:  2014-03-28

3.  Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Authors:  Mart Reimund; Mikael Larsson; Oleg Kovrov; Sergo Kasvandik; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

4.  GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.

Authors:  Xuchen Hu; Geesje M Dallinga-Thie; G Kees Hovingh; Sandy Y Chang; Norma P Sandoval; Tiffany Ly P Dang; Isamu Fukamachi; Kazuya Miyashita; Katsuyuki Nakajima; Masami Murakami; Loren G Fong; Michael Ploug; Stephen G Young; Anne P Beigneux
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

5.  Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).

Authors:  Vineeta Sharma; Andrzej Witkowski; H Ewa Witkowska; Andrew Dykstra; Jens B Simonsen; Lisa Nelbach; Jennifer A Beckstead; Clive R Pullinger; John P Kane; Mary J Malloy; Gordon Watson; Trudy M Forte; Robert O Ryan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-08-14       Impact factor: 8.311

6.  An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1.

Authors:  Christopher M Allan; Mikael Larsson; Xuchen Hu; Cuiwen He; Rachel S Jung; Alaleh Mapar; Constance Voss; Kazuya Miyashita; Tetsuo Machida; Masami Murakami; Katsuyuki Nakajima; André Bensadoun; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2016-08-05       Impact factor: 5.922

7.  Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.

Authors:  Wanee Plengpanich; Stephen G Young; Weerapan Khovidhunkit; André Bensadoun; Hirankorn Karnman; Michael Ploug; Henrik Gårdsvoll; Calvin S Leung; Oludotun Adeyo; Mikael Larsson; Suwanna Muanpetch; Supannika Charoen; Loren G Fong; Sathit Niramitmahapanya; Anne P Beigneux
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

8.  A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time.

Authors:  Shwetha K Shetty; Rosemary L Walzem; Brandon S J Davies
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

Review 9.  Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol.

Authors:  Vineeta Sharma; Trudy M Forte; Robert O Ryan
Journal:  Curr Opin Lipidol       Date:  2013-04       Impact factor: 4.776

Review 10.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.